Home » ALADENT

ALADENT

PERCHE ALADENT?

PERCHE ALADENT? - www.dittafacchini.org

Introduzione
Le infezioni causate da agenti patogeni resistenti ai farmaci sono considerate un grave problema di salute pubblica a livello mondiale. Allo scopo di controbattere le infezioni generate da patogeni resistenti ai farmaci, e per evitare di creare nuove resistenze, negli ultimi anni  è stato dato un forte impulso  alla ricerca di nuove strategie antimicrobiche . Tra queste le molecole fotosensibili occupano un posto sempre di maggior rilievo.

Nel 2019 Alpha Strumenti ha introdotto in odontoiatria un nuovo innovativo  dispositivo medico per  applicazioni fotodinamiche : ALADENT.

Che cosa è ALADENT
E’ un gel termosensibile, coperto da brevetto internazionale, inventato per veicolare l’acido delta-aminolevulinico (5-ALA) nelle mucose.  Una delle sue principali caratteristiche consiste  nel gelificare a temperature superiori ai 28°. Grazie a questo innovativo  gel,  l’acido ( prodotto con purezza non reperibile sul mercato ordinario) può penetrare nelle membrane cellulari e agire  con la massima efficacia.

Come agisce
I tessuti bersaglio e i batteri hanno un’attività metabolica più alta rispetto ai tessuti sani circostanti, per cui accumulano, in maniera selettiva, concentrazioni di precursori e fotosensibilizzanti più elevate rispetto ai tessuti sani. Una volta terminato il processo di “accumulo”, le cellule trasformano il precursore 5 -ALA in un composto endogeno, la Protoporfirina IX (PpIX). Si tratta di un potente fotosensibilizzatore  che si concentra  nelle  cellule bersaglio. La PpIX  accumulata reagisce alla radiazione luminosa sviluppando alti livelli di specie reattive dell’ossigeno (ROS). Sono questi i veri responsabili degli effetti biologici desiderati, e cioè vaso-occlusione locale, danno cellulare e conseguente apoptosi.

Vantaggi di ALADENT  rispetto ad altri dispositivi medici.

  • Termosensibile: si presenta liquido ma gelifica a temperature oltre 28°.
  • Ottima adesione alle mucose
  • Alta selettività e attività verso i biofilm.
  • Non presenta tossicità.
  • La clearance di   PpIX è rapida.
  • Il trattamento è indolore per cui non serve anestesia.
  • Provoca apoptosi con  conseguente risposta immunitaria localizzata.
  • Non necessita l’uso di costose sorgenti luminose laser.
  • Permette la rilevazione ottica tramite  fluorescenza (torcia FL-02).

BIBLIOGRAFIA

  1. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. Photodynamic therapy. J Natl Cancer Inst. 1998 Jun 17;90(12):889-905.
  2. Brown SB, Brown E, Walker I. The present and the future role of photodynamic therapy in cancer treatment. The Lancet Oncology, Vol 5 August 2004: 497-508.
  3. Q Mesquita M, J Dias C, P M S Neves MG, Almeida A, F Faustino MA. Revisiting Current Photoactive Materials for Antimicrobial Photodynamic Therapy. Molecules. 2018 Sep 21;23(10). pii: E2424. doi: 10.3390/molecules23102424.
  4. Fernandes SRG, Fernandes R, Sarmento B, Pereira PMR, Tomé JPC. Photoimmunoconjugates: novel synthetic strategies to target and treat cancer by photodynamic therapy. Org Biomol Chem. 2019 Jan 16. doi: 10.1039/c8ob02902d. [Epub ahead of print] Review. PubMed PMID: 30648722.
  5. Mahmoudi K, Garvey KL, Bouras A, Cramer G, Stepp H, Jesu Raj JG, Bozec D, Busch TM, Hadjipanayis CG. 5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas. J Neurooncol. 2019 Jan 18. doi: 10.1007/s11060-019-03103-4. [Epub ahead of print] Review.
  6. Sperandio FF, Huang YY, Hamblin MR. Antimicrobial photodynamic therapy to kill Gram-negative bacteria. Recent Pat Antiinfect Drug Discov. 2013 Aug;8(2):108-20. PubMed PMID: 23550545; PubMed Central PMCID: PMC3740068.
  7. Javed F, Romanos GE. Does photodynamic therapy enhance standard antibacterial therapy in dentistry? Photomed Laser Surg. 2013 Nov;31(11):512-8. doi: 10.1089/pho.2012.3329. Epub 2013 Oct 19. Review. PubMed PMID: 24138192.
  8. Huang YY, Tanaka M, Vecchio D, Garcia-Diaz M, Chang J, Morimoto Y, Hamblin MR. Photodynamic therapy induces an immune response against a bacterial pathogen. Expert Rev Clin Immunol. 2012 Jul;8(5):479-94. Review.
  9. Reginato E, Wolf P, Hamblin MR. Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects. World J Immunol. 2014 March 27; 4(1): 1–11.
  10. Kharkwal GB, Sharma SK, Huang YY, Dai T, Hamblin MR. Photodynamic therapy for infections: clinical applications. Lasers Surg Med. 2011 Sep;43(7):755-67.
  11. de Oliveira RR, Schwartz-Filho HO, Novaes AB Jr, Taba M Jr. Antimicrobial photodynamic therapy in the non-surgical treatment of aggressive periodontitis: A preliminary randomized controlled clinical study. J Periodontol. 2007; 78(6):965–973. [PubMed: 17539707]
  12. de Oliveira RR, Schwartz-Filho HO, Novaes AB, Garlet GP, de Souza RF, Taba M, Scombatti de Souza SL, Ribeiro FJ. Antimicrobial photodynamic therapy in the non-surgical treatment of aggressive periodontitis: Cytokine profile in gingival crevicular fluid, preliminary results. J Periodontol. 2009; 80(1):98–105. [PubMed: 19228095]
  13. Christodoulides N, Nikolidakis D, Chondros P, Becker J, Schwarz F, Rossler R, Sculean A. Photodynamic therapy as an adjunct to non-surgical periodontal treatment: A randomized, controlled clinical trial. J Periodontol. 2008; 79(9):1638–1644.
  14. Braun A, Dehn C, Krause F, Jepsen S. Short-term clinical effects of adjunctive antimicrobial photodynamic therapy in periodontal treatment: A randomized clinical trial. J Clin Periodontol. 2008; 35(10):877–884.
  15. Sigusch BW, Engelbrecht M, Volpel A, Holletschke A, Pfister W, Schutze J. Full-mouth antimicrobial photodynamic therapy in Fusobacterium nucleatum-infected periodontitis patients. J Periodontol. 2010; 81(7):975–981.
  16. Ruhling A, Fanghanel J, Houshmand M, Kuhr A, Meisel P, Schwahn C, Kocher T. Photodynamic therapy of persistent pockets in maintenance patients—A clinical study. Clin Oral Investig. 2010; 14(6):637–644.
  17. Ge L, Shu R, Li Y, Li C, Luo L, Song Z, Xie Y, Liu D. Adjunctive effect of photodynamic therapy to scaling and root planing in the treatment of chronic periodontitis. Photomed Laser Surg. 2011; 29(1):33–37.
  18. Lui J, Corbet EF, Jin L. Combined photodynamic and low-level laser therapies as an adjunct to nonsurgical treatment of chronic periodontitis. J Periodontal Res. 2011; 46(1):89–96.
  19. Fumes AC, da Silva Telles PD, Corona SAM, Borsatto MC. Effect of aPDT on Streptococcus mutans and Candida albicans present in the dental biofilm: Systematic review. Photodiagnosis Photodyn Ther. 2018 Mar;21:363-366.
  20. Ali IAA, Neelakantan P. Light Activated Disinfection in Root Canal Treatment-A Focused Review. Dent J (Basel). 2018 Jul 10;6(3). pii: E31. doi: 10.3390/dj6030031. Review.
  21. Diogo, P.; Fernandes, C.; Caramelo, F.; Mota, M.; Miranda, I.M.; Faustino, M.A.F.; Neves, M.; Uliana, M.P.; de Oliveira, K.T.; Santos, J.M.; et al. Antimicrobial photodynamic therapy against endodontic enterococcus faecalis and candida albicans mono and mixed biofilms in the presence of photosensitizers: A comparative study with classical endodontic irrigants. Front. Microbiol. 2017, 8, 498
  22. Schiffner, U.; Cachovan, G.; Bastian, J.; Sculean, A.; Eick, S. In vitro activity of photoactivated disinfection using a diode laser in infected root canals. Acta Odontol. Scand. 2014, 72, 673–680.
  23. Garcez AS, Nunez SC, Hamblin MR, Ribeiro MS. Antimicrobial effects of photodynamic therapy on patients with necrotic pulps and periapical lesion. J Endod. 2008; 34(2):138–142.
  24. Tegos GP, Anbe M, Yang C, Demidova TN, Satti M, Mroz P, Janjua S, Gad F, Hamblin MR. Protease-stable polycationic photosensitizer conjugates between polyethyleneimine and chlorin(e6) for broad-spectrum antimicrobial photoinactivation. Antimicrob Agents Chemother 2006; 50(4):1402–1410.
  25. Pinheiro SL, Schenka AA, Neto AA, de Souza CP, Rodriguez HM, Ribeiro MC. Photodynamic therapy in endodontic treatment of deciduous teeth. Lasers Med Sci. 2008
  26. Memar MY, Ghotaslou R, Samiei M, Adibkia K. Infect Drug Resist. Antimicrobial use of reactive oxygen therapy: current insights. 2018 Apr 24;11:567-576. doi: 10.2147/IDR.S142397. eCollection 2018.
  27. Erdtman E, J.V.A. dos Santos D, Löfgrend L, Eriksson LA. Modelling the behavior of 5-aminolevulinic acid and its alkyl esters in a lipid bilayer. Chemical Physics Letters. Volume 463, Issues 1–3, 22 September 2008, Pages 178-182.
  28. Inoue K. 5-Aminolevulinic acid-mediated photodynamic therapy for bladder cancer. Int J Urol. 2017 Feb;24(2):97-101. doi: 10.1111/iju.13291. Review. PubMed PMID: 28191719.
  29. Ferraro N, Barbarite E, Albert TR, Berchmans E, Shah AH, Bregy A, Ivan ME, Brown T, Komotar RJ. The role of 5-aminolevulinic acid in brain tumor surgery: a systematic review. Neurosurg Rev. 2016 Oct;39(4):545-55. Review.
  30. Koizumi N, Harada Y, Minamikawa T, Tanaka H, Otsuji E, Takamatsu T. Recent advances in photodynamic diagnosis of gastric cancer using 5-aminolevulinic acid. World J Gastroenterol. 2016 Jan 21;22(3):1289-96. Review.
  31. Yang X, Palasuberniam P, Kraus D, Chen B. Aminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for Enhancement. Int J Mol Sci. 2015 Oct 28;16(10):25865-80. Review
  32. Vansevičiūtė R, Venius J, Letautienė S. 5-Aminolevulinic acid-based fluorescence diagnostics of cervical preinvasive changes. Medicina (Kaunas). 2014;50(3):137-43. Review.
  33. Itkin A, Gilchrest BA. Delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome. Dermatol Surg. 2004 Jul;30(7):1054-61. Review.
  34. Kawczyk-Krupka A, Latos W, Oleś P, Czuba ZP, Latos M, Krupka M, Pengyun H, Xu C, Cieślar G, Sieroń A. The influence of 5-aminolevulinic photodynamic therapy on colon cancer cell interleukin secretion in hypoxia-like condition in vitro. Photodiagnosis Photodyn Ther. 2018 Sep;23:240-243.
  35. Smetana Z, Malik Z, Orenstein A, Mendelson E, Ben-Hur E. Treatment of viral infections with 5-aminolevulinic acid and light. Lasers Surg Med. 1997; 21(4):351–358.
  36. Hayami J, Okamoto H, Sugihara A, Horio T. Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid. J Dermatol. 2007; 34(5):320–327.
  37. Nitzan Y, Salmon-Divon M, Shporen E, Malik Z. ALA induced photodynamic effects on gram positive and negative bacteria. Photochem Photobiol Sci. 2004 May; 3(5):430-435
  38. Shi H , Li J , Zhang H , Zhang J , Sun H. Effect of 5-aminolevulinic acid photodynamic therapy on Candida albicans biofilms: An in vitro study.Photodiagnosis Photodyn Ther. 2016 Sep;15:40-5.
  39. Li X , Guo H, Tian Q, Zheng G, Hu Y, Fu Y, Tan H. Effects of 5-aminolevulinic acid-mediated photodynamic therapy on antibiotic-resistant staphylococcal biofilm: an in vitro study. J Surg Res. 2013 Oct;184(2):1013-21.
  40. Serini SM, Cannizzaro MV, Dattola A, Garofalo V, Del Duca E, Ventura A, Milani M, Campione E, Bianchi L. The efficacy and tolerability of 5-aminolevulinic acid 5% thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. A two-center, prospective assessor-blinded, proof-of-concept study. J Cosmet Dermatol. 2018 May 22. doi: 10.1111/jocd.12670. [Epub ahead of print]
  41. Radakovic S, Tanew A. 5-aminolaevulinic acid patch-photodynamic therapy in the treatment of actinic cheilitis. Photodermatol Photoimmunol Photomed. 2017 Nov;33(6):306-310. doi: 10.1111/phpp.12332. Epub 2017 Aug 29.
  42. Yew YW, Lai YC, Lim YL, Chong WS, Theng C. Photodynamic Therapy With Topical 5% 5-Aminolevulinic Acid for the Treatment of Truncal Acne in Asian Patients. J Drugs Dermatol. 2016 Jun 1;15(6):727-32.
  43. Yu CH, Chen HM, Lin HP, Chiang CP. Expression of Bak and Bak/Mcl-1 ratio can predict photodynamic therapy outcome for oral verrucous hyperplasia and leukoplakia J Oral Pathol Med (2013) 42: 257–262.
  44. Sieroń A, Adamek M, Kawczyk-Krupka A, Mazur S, Ilewicz L. Photodynamic therapy (PDT) using topically applied delta-aminolevulinic acid (ALA) for the treatment of oral leukoplakia. J Oral Pathol Med. 2003 Jul;32(6):330-6.
  45. Barrett AJ, Kennedy JC, Jones RA, et al. The effect of tissue and cellular pH on the selective biodistribution of porphyrin-type photochemotherapeutic agents: a volumetric titration study. J Photochem Photobiol B 1990; 6: 309–23.
  46. Cieplik F, Deng D, Crielaard W, Buchalla W, Hellwig E, Al-Ahmad A. Antimicrobial photodynamic therapy – what we know and what we don’t. Journal Critical Reviews in Microbiology Volume 44, 2018 – Issue 5
  47. Oleinick NL, Morris RL, Belichenko I. The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci 2002; 1: 1–21.
  48. Gibson SL, Nguyen ML, Havens JJ, Barbarin A, Hilf R. Relationship of delta-aminolevulinic acid-induced protoporphyrin IX levels to mitochondrial content in neoplastic cells in vitro. Biochem Biophys Res Commun. 1999 Nov 19;265(2):315-21.
  49. Moan, Action spectra of dyes relevant for photodynamic therapy; in: Photodynamic Tumor Therapy, 2nd and 3rd generation photosensitizers; J. Moser Ed, Harwood acad. Publish., 1998

PROTOCOLLO

Protocollo Ala dent

 - www.dittafacchini.org

Per ricevere informazioni

info@dittafacchini.org

www.dittafacchini.org

AREA RISERVATA AGLI OPERATORI DEL SETTORE

AREA RISERVATA AGLI OPERATORI DEL SETTORE - www.dittafacchini.org

La zona intranet è destinata agli operatori professionali in ottemperanza alla vigente normativa in materia di pubblicità sanitaria. Pertanto, per visitare il sito, è necessario autenticarsi.